CRL

Charles River Laboratories
Life Sciences Tools & Services · Health Care · as of 2026-11-20
Last close
$315.96
-3.7% on the session
1-year return
+95.5%
+97.1% over six months
Volatility
47.7%
annualized, trailing year
Max drawdown
-33.9%
worst peak to trough, 1y
What the numbers say

Charles River Laboratories is a life sciences tools & services name in the health care sector. Over the past year it returned +95.5%, against +5.8% over three months and -7.0% over one. It trades 36.8% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 47.7% is above the market's typical range.

Its worst peak-to-trough decline over the year was -33.9%, and it has traded a median $283M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.37 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Health Care#7 of 59
Stronger than 90% of its sector on the momentum profile
Across the whole index#5 of 497

How CRL scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 7 others in Life Sciences Tools & Services.

Start a free 7-day trial
Full metrics
1 day-3.7%
1 week-6.5%
1 month-7.0%
3 months+5.8%
6 months+97.1%
1 year+95.5%
12-1 momentum+110.1%
Volatility (1y, annualized)47.7%
Max drawdown (1y)-33.9%
Distance vs 200-day average+36.8%
Return per unit of risk2.00
Median daily dollar volume$283M
Free newsletter

Get CRL when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.